| Application no. and date | 18213309.0 (espacenet) (Federated) (European Patent Register), 20151223 | | Patent/reg. no. and date | DK/EP 3521282, 20210825 | | Publication date | 20190807 | | Priority no. and date | US 201462096748 P, 20141224 | | EP pub. no. and date |
EP 3521282 20190807 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US,
Institute of Organic Chemistry and
Biochemistry AS CR, V.V.I, Flemingovo nam. 2
16610 Praha 6, CZ | | Applicant ref. no. | P77542DK01 | | Inventor | JANSA, Petr, c/o Gilead Sciences Inc
333 Lakeside Drive
Foster City, CA 94404, US,
DEJMEK, Milan, c/o IOCB of the AS CR V.V.I.
Flemingovo Nam. 2.
166 10 Praha 6, CZ,
SIMON, Petr, c/o IOCB of the AS CR V.V.I.
Flemingovo Nam. 2.
166 10 Praha 6, CZ,
BASZCZYNSKI, Ondrej, c/o IOCB of the AS CR V.V.I.
Flemingovo Nam. 2.
166 10 Praha 6, CZ,
LANSDON, Eric, c/o Gilead Sciences Inc
333 Lakeside Drive
Foster City, CA 94404, US,
HU, Yunfeng Eric, c/o Gilead Sciences Inc
333 Lakeside Drive
Foster City, CA 94404, US,
MACKMAN, Richard, L., c/o Gilead Sciences Inc
333 Lakeside Drive
Foster City, CA 94404, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61P 31/18 (2006.01) , C07D 239/94 (2006.01) , C07D 401/12 (2006.01) | | Title | QUINAZOLINDERIVATER ANVENDT TIL BEHANDLING AF HIV | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
